|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:LDLRAD3-TM7SF3 (FusionGDB2 ID:44154) |
Fusion Gene Summary for LDLRAD3-TM7SF3 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: LDLRAD3-TM7SF3 | Fusion gene ID: 44154 | Hgene | Tgene | Gene symbol | LDLRAD3 | TM7SF3 | Gene ID | 143458 | 51768 |
| Gene name | low density lipoprotein receptor class A domain containing 3 | transmembrane 7 superfamily member 3 | |
| Synonyms | LRAD3 | - | |
| Cytomap | 11p13 | 12p11.23 | |
| Type of gene | protein-coding | protein-coding | |
| Description | low-density lipoprotein receptor class A domain-containing protein 3LDLR class A domain-containing protein 3 | transmembrane 7 superfamily member 3seven span transmembrane proteinseven transmembrane protein TM7SF3 | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | Q86YD5 | . | |
| Ensembl transtripts involved in fusion gene | ENST00000524419, ENST00000528989, ENST00000315571, ENST00000529759, | ENST00000343028, ENST00000542667, | |
| Fusion gene scores | * DoF score | 16 X 6 X 10=960 | 4 X 5 X 3=60 |
| # samples | 20 | 4 | |
| ** MAII score | log2(20/960*10)=-2.26303440583379 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(4/60*10)=-0.584962500721156 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: LDLRAD3 [Title/Abstract] AND TM7SF3 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | LDLRAD3(36120011)-TM7SF3(27156323), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Fusion gene breakpoints across LDLRAD3 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene breakpoints across TM7SF3 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | LUAD | TCGA-64-1681-01A | LDLRAD3 | chr11 | 36120011 | - | TM7SF3 | chr12 | 27156323 | - |
Top |
Fusion Gene ORF analysis for LDLRAD3-TM7SF3 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| In-frame | ENST00000524419 | ENST00000343028 | LDLRAD3 | chr11 | 36120011 | - | TM7SF3 | chr12 | 27156323 | - |
| 5CDS-intron | ENST00000524419 | ENST00000542667 | LDLRAD3 | chr11 | 36120011 | - | TM7SF3 | chr12 | 27156323 | - |
| In-frame | ENST00000528989 | ENST00000343028 | LDLRAD3 | chr11 | 36120011 | - | TM7SF3 | chr12 | 27156323 | - |
| 5CDS-intron | ENST00000528989 | ENST00000542667 | LDLRAD3 | chr11 | 36120011 | - | TM7SF3 | chr12 | 27156323 | - |
| In-frame | ENST00000315571 | ENST00000343028 | LDLRAD3 | chr11 | 36120011 | - | TM7SF3 | chr12 | 27156323 | - |
| 5CDS-intron | ENST00000315571 | ENST00000542667 | LDLRAD3 | chr11 | 36120011 | - | TM7SF3 | chr12 | 27156323 | - |
| intron-3CDS | ENST00000529759 | ENST00000343028 | LDLRAD3 | chr11 | 36120011 | - | TM7SF3 | chr12 | 27156323 | - |
| intron-intron | ENST00000529759 | ENST00000542667 | LDLRAD3 | chr11 | 36120011 | - | TM7SF3 | chr12 | 27156323 | - |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000524419 | LDLRAD3 | chr11 | 36120011 | - | ENST00000343028 | TM7SF3 | chr12 | 27156323 | - | 2817 | 425 | 118 | 2046 | 642 |
| ENST00000528989 | LDLRAD3 | chr11 | 36120011 | - | ENST00000343028 | TM7SF3 | chr12 | 27156323 | - | 2817 | 425 | 118 | 2046 | 642 |
| ENST00000315571 | LDLRAD3 | chr11 | 36120011 | - | ENST00000343028 | TM7SF3 | chr12 | 27156323 | - | 2867 | 475 | 21 | 2096 | 691 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000524419 | ENST00000343028 | LDLRAD3 | chr11 | 36120011 | - | TM7SF3 | chr12 | 27156323 | - | 0.000573169 | 0.99942684 |
| ENST00000528989 | ENST00000343028 | LDLRAD3 | chr11 | 36120011 | - | TM7SF3 | chr12 | 27156323 | - | 0.000573169 | 0.99942684 |
| ENST00000315571 | ENST00000343028 | LDLRAD3 | chr11 | 36120011 | - | TM7SF3 | chr12 | 27156323 | - | 0.000526403 | 0.99947363 |
Top |
Fusion Genomic Features for LDLRAD3-TM7SF3 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for LDLRAD3-TM7SF3 |
| Go to FGviewer for the breakpoints of chr11:36120011-chr12:27156323 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| LDLRAD3 | . |
| FUNCTION: May influence APP processing, resulting in a decrease in sAPP-alpha production and increased amyloidogenic P3 peptide production. {ECO:0000250}. | FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | LDLRAD3 | chr11:36120011 | chr12:27156323 | ENST00000315571 | - | 4 | 6 | 112_148 | 151.33333333333334 | 346.0 | Domain | LDL-receptor class A 3 |
| Hgene | LDLRAD3 | chr11:36120011 | chr12:27156323 | ENST00000315571 | - | 4 | 6 | 28_65 | 151.33333333333334 | 346.0 | Domain | LDL-receptor class A 1 |
| Hgene | LDLRAD3 | chr11:36120011 | chr12:27156323 | ENST00000315571 | - | 4 | 6 | 70_107 | 151.33333333333334 | 346.0 | Domain | LDL-receptor class A 2 |
| Tgene | TM7SF3 | chr11:36120011 | chr12:27156323 | ENST00000343028 | 0 | 12 | 297_332 | 30.333333333333332 | 571.0 | Compositional bias | Note=Phe-rich | |
| Tgene | TM7SF3 | chr11:36120011 | chr12:27156323 | ENST00000343028 | 0 | 12 | 296_313 | 30.333333333333332 | 571.0 | Transmembrane | Helical | |
| Tgene | TM7SF3 | chr11:36120011 | chr12:27156323 | ENST00000343028 | 0 | 12 | 320_342 | 30.333333333333332 | 571.0 | Transmembrane | Helical | |
| Tgene | TM7SF3 | chr11:36120011 | chr12:27156323 | ENST00000343028 | 0 | 12 | 347_369 | 30.333333333333332 | 571.0 | Transmembrane | Helical | |
| Tgene | TM7SF3 | chr11:36120011 | chr12:27156323 | ENST00000343028 | 0 | 12 | 371_393 | 30.333333333333332 | 571.0 | Transmembrane | Helical | |
| Tgene | TM7SF3 | chr11:36120011 | chr12:27156323 | ENST00000343028 | 0 | 12 | 408_430 | 30.333333333333332 | 571.0 | Transmembrane | Helical | |
| Tgene | TM7SF3 | chr11:36120011 | chr12:27156323 | ENST00000343028 | 0 | 12 | 437_459 | 30.333333333333332 | 571.0 | Transmembrane | Helical | |
| Tgene | TM7SF3 | chr11:36120011 | chr12:27156323 | ENST00000343028 | 0 | 12 | 479_501 | 30.333333333333332 | 571.0 | Transmembrane | Helical |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | LDLRAD3 | chr11:36120011 | chr12:27156323 | ENST00000315571 | - | 4 | 6 | 274_277 | 151.33333333333334 | 346.0 | Compositional bias | Note=Poly-Pro |
| Hgene | LDLRAD3 | chr11:36120011 | chr12:27156323 | ENST00000315571 | - | 4 | 6 | 18_173 | 151.33333333333334 | 346.0 | Topological domain | Extracellular |
| Hgene | LDLRAD3 | chr11:36120011 | chr12:27156323 | ENST00000315571 | - | 4 | 6 | 195_345 | 151.33333333333334 | 346.0 | Topological domain | Cytoplasmic |
| Hgene | LDLRAD3 | chr11:36120011 | chr12:27156323 | ENST00000315571 | - | 4 | 6 | 174_194 | 151.33333333333334 | 346.0 | Transmembrane | Helical |
Top |
Fusion Gene Sequence for LDLRAD3-TM7SF3 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >In-frame_ENST00000524419_ENST00000343028_TCGA-64-1681-01A_LDLRAD3_chr11_36120011_-_TM7SF3_chr12_27156323_length(transcript)=2817nt_BP=425nt GAAGGCGGGAGGGAGGAGGGCCAGGCGGGAGGGCGGGGACGGCGCGGCGAGGGGCGGGGTCAGCGCCGAGGCCGCGGGGGCAGCAACGAC GCCGGGCAGCGGGAGCGGCGGCCGCGCCATGTGGCTGCTGGGGCCGCTGTGCCTGCTGCTGAGCAGCGCCGCGGCCAAGGCTAAGTCGAA ATGTGGCCCAACCTTCTTCCCCTGTGCCAGCGGCATCCATTGCATCATTGGTCGCTTCCGGTGCAATGGGTTTGAGGACTGTCCCGATGG CAGCGATGAAGAGAACTGCACAGCAAACCCTCTGCTTTGCTCCACCGCCCGCTACCACTGCAAGAACGGCCTCTGTATTGACAAGAGCTT CATCTGCGATGGACAGAATAACTGTCAAGACAACAGTGATGAGGAAAGCTGTGAAAGTTCTCAAGGTCTTATTGAATTTTCTGTGGGGAA ATTTAGATACTTCGAGCTCAATAGGCCCTTTCCAGAGGAAGCTATTTTGCATGATATTTCAAGCAATGTGACTTTTCTTATTTTCCAAAT ACACTCACAGTATCAGAATACAACTGTTTCCTTTTCTCCGACTCTCCTTTCCAATTCCTCGGAAACAGGCACTGCCAGTGGACTGGTTTT CATCCTTAGACCAGAGCAGAGTACATGCACTTGGTACTTGGGGACTTCAGGCATACAGCCTGTCCAGAATATGGCTATCCTACTCTCCTA CTCAGAAAGAGATCCTGTCCCTGGAGGCTGTAATTTGGAGTTCGATTTAGATATTGATCCCAACATTTACTTGGAGTATAATTTCTTTGA AACGACTATCAAGTTTGCCCCAGCAAACCTAGGCTATGCGAGAGGCGTAGATCCCCCACCATGTGACGCTGGGACAGACCAGGACTCCAG GTGGAGGTTGCAGTATGATGTCTATCAGTATTTTCTGCCTGAGAATGACCTCACTGAGGAGATGTTGCTGAAGCATCTGCAGAGGATGGT CAGTGTGCCCCAGGTGAAGGCCAGTGCTCTCAAGGTGGTTACCCTAACAGCTAATGATAAGACAAGTGTTTCCTTCTCCTCCCTCCCGGG ACAAGGTGTCATATACAATGTCATTGTTTGGGACCCGTTTCTAAATACATCTGCTGCCTACATTCCTGCTCACACATACGCTTGCAGCTT TGAGGCAGGAGAGGGTAGTTGTGCTTCCCTAGGAAGAGTGTCTTCCAAAGTGTTCTTCACTCTTTTTGCCCTGCTTGGTTTCTTCATTTG TTTCTTTGGACACAGATTCTGGAAAACAGAATTATTCTTCATAGGCTTTATCATCATGGGATTCTTCTTTTATATACTGATTACAAGACT GACACCTATCAAGTATGATGTGAATCTGATTCTGACAGCTGTCACTGGAAGCGTCGGTGGAATGTTCTTGGTAGCTGTGTGGTGGCGATT TGGAATCCTCTCGATCTGCATGCTCTGTGTTGGACTAGTGCTGGGGTTCCTCATCTCGTCAGTGACTTTCTTTACTCCACTGGGAAACCT AAAGATTTTTCATGATGATGGTGTATTCTGGGTCACTTTCTCTTGCATAGCTATCCTCATTCCAGTAGTTTTCATGGGCTGCCTAAGAAT ACTGAACATACTGACTTGTGGAGTCATTGGCTCCTATTCGGTGGTTTTAGCCATTGACAGTTACTGGTCCACAAGCCTTTCCTACATCAC TTTGAACGTACTCAAGAGAGCGCTCAACAAGGATTTCCACAGAGCTTTCACAAATGTGCCTTTTCAAACTAATGACTTCATTATCCTGGC AGTATGGGGCATGCTGGCTGTAAGTGGAATTACGTTACAGATTCGAAGAGAGAGAGGACGACCGTTCTTCCCTCCCCACCCATACAAGTT ATGGAAGCAAGAGAGAGAGCGCCGAGTGACAAACATTCTGGACCCTAGCTACCACATTCCTCCATTGAGAGAGAGGCTCTATGGCCGATT AACCCAGATTAAAGGGCTCTTCCAGAAGGAGCAGCCAGCTGGAGAGAGAACGCCTTTGCTTCTGTAGATGCCCAGGGGCTTGGTCAGTGT GCCTCAGCTTTGGAGTTCATGCCTGGAGTGGTTCAACAGTCTCTGGTGCAAGTCTAATAAGAGATCAGGCATATATATCTGTTCTTTGCA TAATATTATGGTGCCCTTATTGATATATGGTAAGGGTGTACTAGGGGATTAGGATGATTGTAAGAGAATGAGAAAGATGACCAAAAGGTT GGTGGTAGGGAGGCTTTTTCTTATTTCCAAATACTTGAGAAATTACCTTTTGGTTTACAAATCTATGATCAACTTATTCCATTAAATAGA TACATTAAAAAAATTAAAAACTGATTCTTCTGCAGAGCACTGGTGTTTCTTTTTATAACCCCTTGAAACAAGTCTCTCACCTGAGCCTGT CTAAACTTTCGGAGGGAGTTTATTATTGAGTCTTTATCTGTGACAGTATTTGGAGATTTAGGGATTTGATACTTAGGCCTTTGAATTTTA GAATACAAAAAGAGAAGCAAGCCAGACATGGTGGCTCACACCTGTAATCCCAATACTGGGAAGCCAAGGTGGGAGTATCGCTTGAGCCCA GGAGTTTGAGACCGACATGGGCAACATGACAAGACCCCATCTCTACAAAAAAATTAAAAAATTAGCCAGGCATGGTGGCACATGCCTACT CCCAGCTCCCAAGGAGACTGAGATGGGAGGATCCCTGGAGCCCTGAAGATTGAGGCTACAGTGAGCCTTGATTGTGTCACTGCACTCCAG >In-frame_ENST00000524419_ENST00000343028_TCGA-64-1681-01A_LDLRAD3_chr11_36120011_-_TM7SF3_chr12_27156323_length(amino acids)=642AA_start in transcript=118_stop in transcript=2046 MWLLGPLCLLLSSAAAKAKSKCGPTFFPCASGIHCIIGRFRCNGFEDCPDGSDEENCTANPLLCSTARYHCKNGLCIDKSFICDGQNNCQ DNSDEESCESSQGLIEFSVGKFRYFELNRPFPEEAILHDISSNVTFLIFQIHSQYQNTTVSFSPTLLSNSSETGTASGLVFILRPEQSTC TWYLGTSGIQPVQNMAILLSYSERDPVPGGCNLEFDLDIDPNIYLEYNFFETTIKFAPANLGYARGVDPPPCDAGTDQDSRWRLQYDVYQ YFLPENDLTEEMLLKHLQRMVSVPQVKASALKVVTLTANDKTSVSFSSLPGQGVIYNVIVWDPFLNTSAAYIPAHTYACSFEAGEGSCAS LGRVSSKVFFTLFALLGFFICFFGHRFWKTELFFIGFIIMGFFFYILITRLTPIKYDVNLILTAVTGSVGGMFLVAVWWRFGILSICMLC VGLVLGFLISSVTFFTPLGNLKIFHDDGVFWVTFSCIAILIPVVFMGCLRILNILTCGVIGSYSVVLAIDSYWSTSLSYITLNVLKRALN KDFHRAFTNVPFQTNDFIILAVWGMLAVSGITLQIRRERGRPFFPPHPYKLWKQERERRVTNILDPSYHIPPLRERLYGRLTQIKGLFQK -------------------------------------------------------------- >In-frame_ENST00000528989_ENST00000343028_TCGA-64-1681-01A_LDLRAD3_chr11_36120011_-_TM7SF3_chr12_27156323_length(transcript)=2817nt_BP=425nt GAAGGCGGGAGGGAGGAGGGCCAGGCGGGAGGGCGGGGACGGCGCGGCGAGGGGCGGGGTCAGCGCCGAGGCCGCGGGGGCAGCAACGAC GCCGGGCAGCGGGAGCGGCGGCCGCGCCATGTGGCTGCTGGGGCCGCTGTGCCTGCTGCTGAGCAGCGCCGCGGCCAAGGCTAAGTCGAA ATGTGGCCCAACCTTCTTCCCCTGTGCCAGCGGCATCCATTGCATCATTGGTCGCTTCCGGTGCAATGGGTTTGAGGACTGTCCCGATGG CAGCGATGAAGAGAACTGCACAGCAAACCCTCTGCTTTGCTCCACCGCCCGCTACCACTGCAAGAACGGCCTCTGTATTGACAAGAGCTT CATCTGCGATGGACAGAATAACTGTCAAGACAACAGTGATGAGGAAAGCTGTGAAAGTTCTCAAGGTCTTATTGAATTTTCTGTGGGGAA ATTTAGATACTTCGAGCTCAATAGGCCCTTTCCAGAGGAAGCTATTTTGCATGATATTTCAAGCAATGTGACTTTTCTTATTTTCCAAAT ACACTCACAGTATCAGAATACAACTGTTTCCTTTTCTCCGACTCTCCTTTCCAATTCCTCGGAAACAGGCACTGCCAGTGGACTGGTTTT CATCCTTAGACCAGAGCAGAGTACATGCACTTGGTACTTGGGGACTTCAGGCATACAGCCTGTCCAGAATATGGCTATCCTACTCTCCTA CTCAGAAAGAGATCCTGTCCCTGGAGGCTGTAATTTGGAGTTCGATTTAGATATTGATCCCAACATTTACTTGGAGTATAATTTCTTTGA AACGACTATCAAGTTTGCCCCAGCAAACCTAGGCTATGCGAGAGGCGTAGATCCCCCACCATGTGACGCTGGGACAGACCAGGACTCCAG GTGGAGGTTGCAGTATGATGTCTATCAGTATTTTCTGCCTGAGAATGACCTCACTGAGGAGATGTTGCTGAAGCATCTGCAGAGGATGGT CAGTGTGCCCCAGGTGAAGGCCAGTGCTCTCAAGGTGGTTACCCTAACAGCTAATGATAAGACAAGTGTTTCCTTCTCCTCCCTCCCGGG ACAAGGTGTCATATACAATGTCATTGTTTGGGACCCGTTTCTAAATACATCTGCTGCCTACATTCCTGCTCACACATACGCTTGCAGCTT TGAGGCAGGAGAGGGTAGTTGTGCTTCCCTAGGAAGAGTGTCTTCCAAAGTGTTCTTCACTCTTTTTGCCCTGCTTGGTTTCTTCATTTG TTTCTTTGGACACAGATTCTGGAAAACAGAATTATTCTTCATAGGCTTTATCATCATGGGATTCTTCTTTTATATACTGATTACAAGACT GACACCTATCAAGTATGATGTGAATCTGATTCTGACAGCTGTCACTGGAAGCGTCGGTGGAATGTTCTTGGTAGCTGTGTGGTGGCGATT TGGAATCCTCTCGATCTGCATGCTCTGTGTTGGACTAGTGCTGGGGTTCCTCATCTCGTCAGTGACTTTCTTTACTCCACTGGGAAACCT AAAGATTTTTCATGATGATGGTGTATTCTGGGTCACTTTCTCTTGCATAGCTATCCTCATTCCAGTAGTTTTCATGGGCTGCCTAAGAAT ACTGAACATACTGACTTGTGGAGTCATTGGCTCCTATTCGGTGGTTTTAGCCATTGACAGTTACTGGTCCACAAGCCTTTCCTACATCAC TTTGAACGTACTCAAGAGAGCGCTCAACAAGGATTTCCACAGAGCTTTCACAAATGTGCCTTTTCAAACTAATGACTTCATTATCCTGGC AGTATGGGGCATGCTGGCTGTAAGTGGAATTACGTTACAGATTCGAAGAGAGAGAGGACGACCGTTCTTCCCTCCCCACCCATACAAGTT ATGGAAGCAAGAGAGAGAGCGCCGAGTGACAAACATTCTGGACCCTAGCTACCACATTCCTCCATTGAGAGAGAGGCTCTATGGCCGATT AACCCAGATTAAAGGGCTCTTCCAGAAGGAGCAGCCAGCTGGAGAGAGAACGCCTTTGCTTCTGTAGATGCCCAGGGGCTTGGTCAGTGT GCCTCAGCTTTGGAGTTCATGCCTGGAGTGGTTCAACAGTCTCTGGTGCAAGTCTAATAAGAGATCAGGCATATATATCTGTTCTTTGCA TAATATTATGGTGCCCTTATTGATATATGGTAAGGGTGTACTAGGGGATTAGGATGATTGTAAGAGAATGAGAAAGATGACCAAAAGGTT GGTGGTAGGGAGGCTTTTTCTTATTTCCAAATACTTGAGAAATTACCTTTTGGTTTACAAATCTATGATCAACTTATTCCATTAAATAGA TACATTAAAAAAATTAAAAACTGATTCTTCTGCAGAGCACTGGTGTTTCTTTTTATAACCCCTTGAAACAAGTCTCTCACCTGAGCCTGT CTAAACTTTCGGAGGGAGTTTATTATTGAGTCTTTATCTGTGACAGTATTTGGAGATTTAGGGATTTGATACTTAGGCCTTTGAATTTTA GAATACAAAAAGAGAAGCAAGCCAGACATGGTGGCTCACACCTGTAATCCCAATACTGGGAAGCCAAGGTGGGAGTATCGCTTGAGCCCA GGAGTTTGAGACCGACATGGGCAACATGACAAGACCCCATCTCTACAAAAAAATTAAAAAATTAGCCAGGCATGGTGGCACATGCCTACT CCCAGCTCCCAAGGAGACTGAGATGGGAGGATCCCTGGAGCCCTGAAGATTGAGGCTACAGTGAGCCTTGATTGTGTCACTGCACTCCAG >In-frame_ENST00000528989_ENST00000343028_TCGA-64-1681-01A_LDLRAD3_chr11_36120011_-_TM7SF3_chr12_27156323_length(amino acids)=642AA_start in transcript=118_stop in transcript=2046 MWLLGPLCLLLSSAAAKAKSKCGPTFFPCASGIHCIIGRFRCNGFEDCPDGSDEENCTANPLLCSTARYHCKNGLCIDKSFICDGQNNCQ DNSDEESCESSQGLIEFSVGKFRYFELNRPFPEEAILHDISSNVTFLIFQIHSQYQNTTVSFSPTLLSNSSETGTASGLVFILRPEQSTC TWYLGTSGIQPVQNMAILLSYSERDPVPGGCNLEFDLDIDPNIYLEYNFFETTIKFAPANLGYARGVDPPPCDAGTDQDSRWRLQYDVYQ YFLPENDLTEEMLLKHLQRMVSVPQVKASALKVVTLTANDKTSVSFSSLPGQGVIYNVIVWDPFLNTSAAYIPAHTYACSFEAGEGSCAS LGRVSSKVFFTLFALLGFFICFFGHRFWKTELFFIGFIIMGFFFYILITRLTPIKYDVNLILTAVTGSVGGMFLVAVWWRFGILSICMLC VGLVLGFLISSVTFFTPLGNLKIFHDDGVFWVTFSCIAILIPVVFMGCLRILNILTCGVIGSYSVVLAIDSYWSTSLSYITLNVLKRALN KDFHRAFTNVPFQTNDFIILAVWGMLAVSGITLQIRRERGRPFFPPHPYKLWKQERERRVTNILDPSYHIPPLRERLYGRLTQIKGLFQK -------------------------------------------------------------- >In-frame_ENST00000315571_ENST00000343028_TCGA-64-1681-01A_LDLRAD3_chr11_36120011_-_TM7SF3_chr12_27156323_length(transcript)=2867nt_BP=475nt AGCGGGAGCGGCGGCCGCGCCATGTGGCTGCTGGGGCCGCTGTGCCTGCTGCTGAGCAGCGCCGCGGAGAGCCAGCTGCTCCCCGGGAAC AACTTCACCAATGAGTGCAACATACCAGGCAACTTCATGTGCAGCAATGGACGGTGCATCCCGGGCGCCTGGCAGTGTGACGGGCTGCCT GACTGCTTCGACAAGAGTGATGAGAAGGAGTGCCCCAAGGCTAAGTCGAAATGTGGCCCAACCTTCTTCCCCTGTGCCAGCGGCATCCAT TGCATCATTGGTCGCTTCCGGTGCAATGGGTTTGAGGACTGTCCCGATGGCAGCGATGAAGAGAACTGCACAGCAAACCCTCTGCTTTGC TCCACCGCCCGCTACCACTGCAAGAACGGCCTCTGTATTGACAAGAGCTTCATCTGCGATGGACAGAATAACTGTCAAGACAACAGTGAT GAGGAAAGCTGTGAAAGTTCTCAAGGTCTTATTGAATTTTCTGTGGGGAAATTTAGATACTTCGAGCTCAATAGGCCCTTTCCAGAGGAA GCTATTTTGCATGATATTTCAAGCAATGTGACTTTTCTTATTTTCCAAATACACTCACAGTATCAGAATACAACTGTTTCCTTTTCTCCG ACTCTCCTTTCCAATTCCTCGGAAACAGGCACTGCCAGTGGACTGGTTTTCATCCTTAGACCAGAGCAGAGTACATGCACTTGGTACTTG GGGACTTCAGGCATACAGCCTGTCCAGAATATGGCTATCCTACTCTCCTACTCAGAAAGAGATCCTGTCCCTGGAGGCTGTAATTTGGAG TTCGATTTAGATATTGATCCCAACATTTACTTGGAGTATAATTTCTTTGAAACGACTATCAAGTTTGCCCCAGCAAACCTAGGCTATGCG AGAGGCGTAGATCCCCCACCATGTGACGCTGGGACAGACCAGGACTCCAGGTGGAGGTTGCAGTATGATGTCTATCAGTATTTTCTGCCT GAGAATGACCTCACTGAGGAGATGTTGCTGAAGCATCTGCAGAGGATGGTCAGTGTGCCCCAGGTGAAGGCCAGTGCTCTCAAGGTGGTT ACCCTAACAGCTAATGATAAGACAAGTGTTTCCTTCTCCTCCCTCCCGGGACAAGGTGTCATATACAATGTCATTGTTTGGGACCCGTTT CTAAATACATCTGCTGCCTACATTCCTGCTCACACATACGCTTGCAGCTTTGAGGCAGGAGAGGGTAGTTGTGCTTCCCTAGGAAGAGTG TCTTCCAAAGTGTTCTTCACTCTTTTTGCCCTGCTTGGTTTCTTCATTTGTTTCTTTGGACACAGATTCTGGAAAACAGAATTATTCTTC ATAGGCTTTATCATCATGGGATTCTTCTTTTATATACTGATTACAAGACTGACACCTATCAAGTATGATGTGAATCTGATTCTGACAGCT GTCACTGGAAGCGTCGGTGGAATGTTCTTGGTAGCTGTGTGGTGGCGATTTGGAATCCTCTCGATCTGCATGCTCTGTGTTGGACTAGTG CTGGGGTTCCTCATCTCGTCAGTGACTTTCTTTACTCCACTGGGAAACCTAAAGATTTTTCATGATGATGGTGTATTCTGGGTCACTTTC TCTTGCATAGCTATCCTCATTCCAGTAGTTTTCATGGGCTGCCTAAGAATACTGAACATACTGACTTGTGGAGTCATTGGCTCCTATTCG GTGGTTTTAGCCATTGACAGTTACTGGTCCACAAGCCTTTCCTACATCACTTTGAACGTACTCAAGAGAGCGCTCAACAAGGATTTCCAC AGAGCTTTCACAAATGTGCCTTTTCAAACTAATGACTTCATTATCCTGGCAGTATGGGGCATGCTGGCTGTAAGTGGAATTACGTTACAG ATTCGAAGAGAGAGAGGACGACCGTTCTTCCCTCCCCACCCATACAAGTTATGGAAGCAAGAGAGAGAGCGCCGAGTGACAAACATTCTG GACCCTAGCTACCACATTCCTCCATTGAGAGAGAGGCTCTATGGCCGATTAACCCAGATTAAAGGGCTCTTCCAGAAGGAGCAGCCAGCT GGAGAGAGAACGCCTTTGCTTCTGTAGATGCCCAGGGGCTTGGTCAGTGTGCCTCAGCTTTGGAGTTCATGCCTGGAGTGGTTCAACAGT CTCTGGTGCAAGTCTAATAAGAGATCAGGCATATATATCTGTTCTTTGCATAATATTATGGTGCCCTTATTGATATATGGTAAGGGTGTA CTAGGGGATTAGGATGATTGTAAGAGAATGAGAAAGATGACCAAAAGGTTGGTGGTAGGGAGGCTTTTTCTTATTTCCAAATACTTGAGA AATTACCTTTTGGTTTACAAATCTATGATCAACTTATTCCATTAAATAGATACATTAAAAAAATTAAAAACTGATTCTTCTGCAGAGCAC TGGTGTTTCTTTTTATAACCCCTTGAAACAAGTCTCTCACCTGAGCCTGTCTAAACTTTCGGAGGGAGTTTATTATTGAGTCTTTATCTG TGACAGTATTTGGAGATTTAGGGATTTGATACTTAGGCCTTTGAATTTTAGAATACAAAAAGAGAAGCAAGCCAGACATGGTGGCTCACA CCTGTAATCCCAATACTGGGAAGCCAAGGTGGGAGTATCGCTTGAGCCCAGGAGTTTGAGACCGACATGGGCAACATGACAAGACCCCAT CTCTACAAAAAAATTAAAAAATTAGCCAGGCATGGTGGCACATGCCTACTCCCAGCTCCCAAGGAGACTGAGATGGGAGGATCCCTGGAG >In-frame_ENST00000315571_ENST00000343028_TCGA-64-1681-01A_LDLRAD3_chr11_36120011_-_TM7SF3_chr12_27156323_length(amino acids)=691AA_start in transcript=21_stop in transcript=2096 MWLLGPLCLLLSSAAESQLLPGNNFTNECNIPGNFMCSNGRCIPGAWQCDGLPDCFDKSDEKECPKAKSKCGPTFFPCASGIHCIIGRFR CNGFEDCPDGSDEENCTANPLLCSTARYHCKNGLCIDKSFICDGQNNCQDNSDEESCESSQGLIEFSVGKFRYFELNRPFPEEAILHDIS SNVTFLIFQIHSQYQNTTVSFSPTLLSNSSETGTASGLVFILRPEQSTCTWYLGTSGIQPVQNMAILLSYSERDPVPGGCNLEFDLDIDP NIYLEYNFFETTIKFAPANLGYARGVDPPPCDAGTDQDSRWRLQYDVYQYFLPENDLTEEMLLKHLQRMVSVPQVKASALKVVTLTANDK TSVSFSSLPGQGVIYNVIVWDPFLNTSAAYIPAHTYACSFEAGEGSCASLGRVSSKVFFTLFALLGFFICFFGHRFWKTELFFIGFIIMG FFFYILITRLTPIKYDVNLILTAVTGSVGGMFLVAVWWRFGILSICMLCVGLVLGFLISSVTFFTPLGNLKIFHDDGVFWVTFSCIAILI PVVFMGCLRILNILTCGVIGSYSVVLAIDSYWSTSLSYITLNVLKRALNKDFHRAFTNVPFQTNDFIILAVWGMLAVSGITLQIRRERGR -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for LDLRAD3-TM7SF3 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for LDLRAD3-TM7SF3 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for LDLRAD3-TM7SF3 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | LDLRAD3 | C0013146 | Drug abuse | 1 | CTD_human |
| Hgene | LDLRAD3 | C0013170 | Drug habituation | 1 | CTD_human |
| Hgene | LDLRAD3 | C0013222 | Drug Use Disorders | 1 | CTD_human |
| Hgene | LDLRAD3 | C0029231 | Organic Mental Disorders, Substance-Induced | 1 | CTD_human |
| Hgene | LDLRAD3 | C0038580 | Substance Dependence | 1 | CTD_human |
| Hgene | LDLRAD3 | C0038586 | Substance Use Disorders | 1 | CTD_human |
| Hgene | LDLRAD3 | C0236969 | Substance-Related Disorders | 1 | CTD_human |
| Hgene | LDLRAD3 | C0740858 | Substance abuse problem | 1 | CTD_human |
| Hgene | LDLRAD3 | C1510472 | Drug Dependence | 1 | CTD_human |
| Hgene | LDLRAD3 | C4316881 | Prescription Drug Abuse | 1 | CTD_human |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies